MedTrace Logo

Male Fertility and Sperm Cryopreservation

NCT02431000 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2020-11-13

No results posted yet for this study

Summary

PURPOSE: Primary objective: To assess the feasibility and outcomes of male fertility preservation by sperm freezing prior to starting treatment requiring alkylating agents and/or total body irradiation.

Secondary objective: To assess pre- and post-treatment sperm production and hormonal status by measurement of serum anti-mullerian hormone (AMH), inhibin-B, follicle stimulating hormone (FSH), luteinizing hormone (LH), testosterone, and androstendione.

Conditions

Interventions

PROCEDURE

Sperm and blood collected for analysis

Sperm Collection and Freezing (Cryopreservation), Blood Collection for analysis

Sponsors & Collaborators

  • University of Tennessee

    lead OTHER

Principal Investigators

  • Laura Detti, M.D. · Associate Professor, UTennessee Health Science Center

Eligibility

Min Age
13 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02431000 on ClinicalTrials.gov